Skip to main content
Premium Trial:

Request an Annual Quote

Natera Inks Distribution Deal With TomaLab for Italy

NEW YORK — TomaLab said on Tuesday that it has signed an agreement with Natera to distribute three of that firm's cell-free DNA tests in Italy.

Under the terms of the deal, Busto Arsizio, Italy-based TomaLab will distribute Natera's Panorama noninvasive prenatal test, Signatera circulating tumor DNA test for cancer treatment monitoring and minimal residual disease assessment, and Prospera test for assessing transplant rejection.

Financial and other terms were not disclosed.

Earlier this year, San Carlos, California-based Natera reported a 62 percent jump in first quarter revenues amid growing demand for its tests.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.